Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA)

43Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

1. Cis-9,10-octadecenoamide (cOA) accumulates in the CSF of sleep-deprived cats and may represent a novel signalling molecule. Synthetic cOA has been shown to induce physiological sleep when injected into laboratory rats. Here we assess the cellular mode of action of cOA in vitro. 2. In all rat cultured cortical neurones (pyramidal cells) examined, the synthetic brain lipid (3.2-64 μM) enhanced the responses to subsaturating GABA concentrations (up to circa 2x) in a concentration-dependent manner (EC50, circa 15 μM). 3. (20 μM) cOA significantly enhanced the affinity of exogenous GABA for its receptor without changing the Hill slope or the maximal response. These effects were not voltage-dependent or secondary to shifts in E(Cl). 4. In the absence of GABA, cOA directly evoked small inhibitory currents in a subpopulation (< 7%) of sensitive cells. 5. 20 μM cOA reversibly enhanced the duration of spontaneous inhibitory post synaptic currents (circa 2 fold) without significantly altering their amplitude. 6. At 32-64 μM cOA reversibly reduced the incidence and amplitude of both inhibitory post synaptic currents (i.p.s.cs) and excitatory post synaptic currents (e.p.s.cs) in the cultured neuronal circuits in common with other depressant drugs acting at the GABA(A) receptor. 7. 32 μM Oleic acid did not modulate exogenous GABA currents or synaptic activity suggesting that cOAs actions are mediated through a specific receptor. 8. A specific, protein-dependent interaction with GABA(A) receptors was confirmed in Xenopus oocytes. Recombinant human receptors were modulated by 10 μM cOA (and diazepam) only when a γ2 subunit was co-expressed with α1β2: the cOA response was not sensitive to the specific benzodiazepine antagonist flumazenil (1 μM). 8. cOA may represent an endogenous ligand for allosteric modulatory sites on isoforms of GABA(A) receptors which are crucial for the regulation of arousal and have recently been implicated in the circadian control of physiological sleep.

References Powered by Scopus

Which GABA<inf>A</inf>-receptor subtypes really occur in the brain?

1105Citations
N/AReaders
Get full text

Selective antagonists of benzodiazepines

1074Citations
N/AReaders
Get full text

Chemical characterization of a family of brain lipids that induce sleep

566Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Structure and function of fatty acid amide hydrolase

596Citations
N/AReaders
Get full text

GABA-activated ligand gated ion channels: Medicinal chemistry and molecular biology

310Citations
N/AReaders
Get full text

A second fatty acid amide hydrolase with variable distribution among placental mammals

301Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lees, G., Edwards, M. D., Hassoni, A. A., Ganellin, C. R., & Galanakis, D. (1998). Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). British Journal of Pharmacology, 124(5), 873–882. https://doi.org/10.1038/sj.bjp.0701918

Readers' Seniority

Tooltip

Researcher 4

44%

Professor / Associate Prof. 3

33%

PhD / Post grad / Masters / Doc 2

22%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 6

55%

Neuroscience 3

27%

Pharmacology, Toxicology and Pharmaceut... 1

9%

Psychology 1

9%

Save time finding and organizing research with Mendeley

Sign up for free